Popular news

Akers Biosciences Secures Further Intellectual Property Protection for Akers Wellness Line
Primary analysis results from Novartis pivotal JULIET trial show Kymriah(TM) (tisagenlecleucel) sustained complete responses at six months in adults with r/r DLBCL, a difficult-to-treat cancer
Télé-Québec adopts the DiliTrust Exec’s board portal for the digital transition of its board of directors
Davidson Kempner Capital Management LP : Form 8.3 - GVC Holdings plc
Ahold Delhaize announces Ahold Delhaize USA, a new parent company for its U.S. businesses; appoints Kevin Holt CEO Ahold Delhaize USA
Catalyst Biosciences Announces Interim Phase 1/2 CB 2679d/ISU304 Results at the American Society of Hematology Conference
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Omega Healthcare Investors, Inc. of Class Action Lawsuit and Upcoming Deadline – OHI
Fate Therapeutics Announces Generation of CAR-targeted, TCR-null CD8αβ+ T Cells from Clonal Engineered Master Pluripotent Cell Line for Off-the-Shelf T-cell Immunotherapy
Bellicum Announces Data Presentation Demonstrating Improved Immune Recovery Following Haploidentical Stem Cell Transplant with BPX-501 in Children with Blood Cancers and Nonmalignant Diseases
Associa Cares Donates up to $100,000 for California Fire Relief

Copyright Euroinvestor A/S 2017   Disclaimer and Terms of Use
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
13 December 2017 01:57:03
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20171124.1 - EUROWEB1 - 2017-12-13 02:57:03 - 2017-12-13 01:57:03 - 1000 - Website: OKAY